EP 2344487 A4 20120321 - HEPATITIS C INHIBITOR COMPOUNDS
Title (en)
HEPATITIS C INHIBITOR COMPOUNDS
Title (de)
HEPATITIS-C-HEMMER-VERBINDUNGEN
Title (fr)
COMPOSÉS INHIBITEURS DE L'HÉPATITE C
Publication
Application
Priority
- CA 2009001237 W 20090914
- US 9929208 P 20080923
- US 18663209 P 20090612
Abstract (en)
[origin: WO2010034105A1] Compounds of Formula (I): wherein B, R3, L0, L1, R2, Rc and R1 are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection. In particular, the present invention provides novel peptide analogs, pharmaceutical compositions containing such analogs, and uses of these analogs in the treatment of HCV infection
IPC 8 full level
C07D 417/14 (2006.01); A61K 31/4709 (2006.01); A61K 31/506 (2006.01); A61P 31/14 (2006.01)
CPC (source: EP)
A61P 31/14 (2017.12); C07D 417/14 (2013.01); C07K 5/0808 (2013.01); C07K 5/0812 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
- No further relevant documents disclosed
- See references of WO 2010034105A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
DOCDB simple family (publication)
WO 2010034105 A1 20100401; WO 2010034105 A8 20110106; AR 073659 A1 20101124; CA 2737958 A1 20100401; EP 2344487 A1 20110720; EP 2344487 A4 20120321; JP 2012502925 A 20120202; TW 201016694 A 20100501
DOCDB simple family (application)
CA 2009001237 W 20090914; AR P090103651 A 20090922; CA 2737958 A 20090914; EP 09815517 A 20090914; JP 2011527161 A 20090914; TW 98131961 A 20090922